kohdehoitoja

Kohdehoitoja, often translated as targeted therapies, represents a class of cancer treatments that work by interfering with specific molecules that are involved in cancer cell growth and survival. Unlike traditional chemotherapy, which affects all rapidly dividing cells, kohdehoitoja are designed to target particular abnormalities within cancer cells. This can lead to fewer side effects compared to conventional chemotherapy because healthy cells are less likely to be harmed.

These therapies can work in several ways. Some drugs block the signals that tell cancer cells to grow and divide. Others help the immune system to recognize and destroy cancer cells. Certain kohdehoitoja work by preventing the formation of new blood vessels that tumors need to grow. Still others deliver toxic substances directly to cancer cells, or help the body's own DNA repair mechanisms to fix damage in cancer cells.

The development and use of kohdehoitoja rely heavily on understanding the genetic and molecular makeup of an individual's tumor. This often involves diagnostic tests to identify specific mutations or protein expressions that can be targeted. The effectiveness of these treatments can vary greatly depending on the type of cancer and the specific genetic alterations present. While offering a more precise approach to cancer treatment, kohdehoitoja are not a cure-all and may not be suitable for all patients or all types of cancer.